Mostrando 5 resultados de: 5
Filtros aplicados
Publisher
Clinical Gastroenterology and Hepatology(1)
Clinical Nutrition(1)
Hepatitis Monthly(1)
Journal of Clinical Gastroenterology(1)
Liver International(1)
Early Age Hepatocellular Carcinoma Associated With Hepatitis B Infection in South America
OtherAbstract:Palabras claves:Autores:Avendaño K., Balderramo D., Ballerga E.G., Barreyro F.J., Cairo F., Carrilho F.J., Chan A.J., Davalos M.B., Debes J.D., Enrique Carrera, Ferrer J.D., Gonçalves P.T., Hernández N., Hirsch B.S., Idrovo V., Kikuchi L., Mattos A.Z., Paredes S., Prieto J.E., Roberts L.R., Tapias M., Yang J.D.Fuentes:scopusHepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy
ArticleAbstract: Background & Aims: Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related deatPalabras claves:demographics, hepatocellular carcinoma, RISK FACTORS, SOUTH AMERICAAutores:Avendaño K., Balderramo D., Barreyro F.J., Cairo F., Carrilho F.J., Chan A.J., Davalos M.B., Debes J.D., Diaz-Ferrer J., Enrique Carrera, Garcia J.A., Gonçalves P.T., Gonzalez-Ballerga E., Hernández N., Hirsch B.S., Idrovo V., Kikuchi L., Mattos A.Z., Paredes S., Prieto J.E., Roberts L.R., Tapias M., Yang J.D.Fuentes:scopusOmega-3 PUFA modulate lipogenesis, ER stress, and mitochondrial dysfunction markers in NASH – Proteomic and lipidomic insight
ArticleAbstract: Background & aims: Currently there is no FDA-approved therapy for nonalcoholic steatohepatitis (NASHPalabras claves:Endoplasmic reticulum stress, Lipidomic, mitochondrial dysfunction, NASH, Omega-3 PUFA, ProteomicAutores:Alves V.A.F., Carrilho F.J., Fernanda Bertuccez Cordeiro, Nogueira M.A., Okada L.S.d.R.R., Oliveira C.P., Puri P., Silva I.D.C.G.d., Stefano J.T., Torrinhas R.S., Waitzberg D.L.Fuentes:scopusPIB: A score to select sorafenib treatment candidates for hepatocellular carcinoma in resource-limited settings
ArticleAbstract:Palabras claves:HCC, hepatocellular carcinoma, SCORE, SorafenibAutores:Balderramo D., Barreyro F.J., Carrilho F.J., Debes J.D., Diaz-Ferrer J., Diehl F., Enrique Carrera, Ferreiro M.R., Gonzalez-Ballerga E., Leathers J.S., Mattos A.Z., Prieto J.E., Singh D.Fuentes:scopusSorafenib for Treatment of Hepatocellular Carcinoma: A Survival Analysis from the South American Liver Research Network
ArticleAbstract: Goals:We aim to describe the efficacy, safety profile, and variables associated with survival in patPalabras claves:hepatocellular carcinoma, Sorafenib, SOUTH AMERICA, SurvivalAutores:Balderramo D., Barreyro F.J., Carrilho F.J., Debes J.D., Diaz-Ferrer J., Diehl F., Enrique Carrera, Ferreiro M.R., Gonzalez-Ballerga E., Leathers J.S., Mattos A.Z., Prieto J.E., Singh D.Fuentes:scopus